Evidence map›Paper›PMID 41721036›Full record

ArticleThe protein journal2026

Effects of Arginine on Hierarchical Protein Aggregation.

Suguru Nishinami, Yoshiki Kihara, Teruo Akuta, Kentaro Shiraki, Tsutomu Arakawa

Abstract read
PubMed Publisher
In one paragraph

Article in The protein journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Suguru Nishinami *Institute of Pure and Applied Sciences, University of Tsukuba, Tsukuba, Japan. nishinami@igm.hokudai.ac.jp.
Yoshiki Kihara *Institute of Pure and Applied Sciences, University of Tsukuba, Tsukuba, Japan.
Teruo AkutaResearch and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., Takahagi, Japan.
Kentaro ShirakiInstitute of Pure and Applied Sciences, University of Tsukuba, Tsukuba, Japan.
Tsutomu ArakawaAlliance Protein Laboratories, San Diego, CA, USA. tarakawa2@aol.com.

Funding

Japan Society for the Promotion of Science 22K19284
6 · The paper itself

Abstract

Arginine is widely used in protein formulations to suppress protein aggregation and prolong the lifetime of the native, functional state which undergoes different stresses during storage, shipping and handling. However, arginine's differential effects on protein aggregation pathways remain unclear. Here, we investigated the effects of arginine on heat- and acid-induced aggregation of immunoglobulin G and heat-induced aggregation of several model proteins. Arginine suppressed the formation of insoluble aggregates but had limited impact on monomer recovery, particularly on immunoglobulin G. Instead, arginine promoted the formation of soluble aggregates, suggesting a possibility that unfolded proteins possess heterogeneous surface properties, leading to formation of soluble and insoluble aggregates that are modulated by arginine. To explain these kinetic behaviors, we propose a hierarchical aggregation model, in which arginine preferentially modulates weaker intermolecular interactions to inhibit the growth of the soluble aggregates into large insoluble aggregates. Moreover, soluble aggregates were observed in a range of proteins with varying isoelectric points and molecular weights. These results highlight a previously unrecognized aspect of soluble protein aggregation. Understanding the pathway and mechanism of soluble aggregate formation may shed light into physiologically-relevant soluble assemblies, e.g., Alzheimer's disease-associated oligomers and microtubule-derived double rings in contrast to the soluble amorphous aggregates under current study.

Indexed as

ArginineImmunoglobulin GProtein AggregatesAnimalsHot TemperatureHumansKineticsSolubilityArginineImmunoglobulin GProtein AggregatesAdditive–protein interactionArginineProtein aggregationSoluble aggregates

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.